Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

We Have More Data Than We Know What to Do With
Every year brings another round of headlines about pharma “drowning in data.” At this point, that’s less a warning than a permanent weather condition. read more
The Human Advantage in ADME Testing
Animal models do not accurately recapitulate several aspects of human physiology, and these differences lead to variations in drug behaviors across species. Each contributes useful evidence, but what is missing is the connected human biology needed to predict ADME behavior with confidence. read more
The Next Test for AI in Pharmacovigilance Is Trust, Not Accuracy
An AI model can be right and still not be trusted. That’s what Bristol Myers Squibb (BMS) found six months into rolling out AI-powered adverse event processing: while F1 performance scores were tracking upward, the audit trail found reviewers still reopening cases the system had already cleared. read more
The Importance of a Hybrid Testing Approach for Safety Assessments in the NAM-Enabled Era
For decades, in vivo models have been the standard in preclinical testing before a drug moves to first-in-human (FIH) trials. But a recent evolution in regulatory expectations has accelerated a steady shift away from in vivo testing, in favor of New Approach Methodologies (NAMs). read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Transpharmation Acquires OrganoTherapeutics to Add Human Brain Models
Thursday, October 29, 2026
Transpharmation has acquired Luxembourg-based OrganoTherapeutics, adding human stem cell-derived brain models to its preclinical contract research ... read more
Codis Begins Construction on Haverhill Spray Drying Expansion
Thursday, October 29, 2026
Codis has completed demolition and begun construction on an expansion at its Haverhill, United Kingdom, site that will add commercial-scale spray ... read more
Adalvo Acquires Enzene’s Romiplostim Biosimilar Program
Thursday, October 29, 2026
Adalvo has acquired global rights to Enzene’s romiplostim biosimilar program, while the Pune-based company will retain responsibility for development ... read more
Piramal’s Pithampur Site Wins Internal Award for Patient Dashboard
Tuesday, October 27, 2026
Piramal Pharma Solutions’ Pithampur manufacturing site in India has won the company’s annual Excellence in Patient Centricity Award for a digital ... read more
BioAgilytix Opens Sydney Bioanalytical Laboratory
Monday, October 26, 2026
BioAgilytix has opened a laboratory in Sydney through its Australian subsidiary, 360biolabs, expanding its capacity to process clinical trial samples ... read more